The pricing structure of the healthcare and drug distribution industry has been wrecked and Wall Street is taking down those stocks as a result, says TheStreet's Jim Cramer. After Thursday's closing bell, the San Francisco-based pharmaceutical distributor McKesson (MCK) reported adjusted earnings of $2.94 a share on revenue of $49.96 billion. Analysts were looking for adjusted earnings of $3.04 a share on revenue of $51.21 billion. The company said results were impacted by a "softer pricing environment" in its U.S. pharmaceutical business. Cardinal Health (CAH) , which is trading down in sympathy, is set to report first-quarter fiscal 2017 earnings results on Oct 31.
More from Video
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.
Citi overcame a mixed print to send its stock surging on Monday.